Shares of Coloplast A/S (NASDAQ:CLPBY) have earned an average broker rating score of 4.00 (Sell) from the one analysts that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a sell rating.
Zacks has also given Coloplast A/S an industry rank of 174 out of 265 based on the ratings given to its competitors.
Separately, Zacks Investment Research upgraded Coloplast A/S from a “hold” rating to a “buy” rating and set a $9.00 price objective on the stock in a research note on Wednesday, September 6th.
Shares of Coloplast A/S (NASDAQ:CLPBY) opened at $8.12 on Wednesday. Coloplast A/S has a one year low of $6.14 and a one year high of $8.88.
ILLEGAL ACTIVITY WARNING: “Coloplast A/S (CLPBY) Given Consensus Rating of “Sell” by Brokerages” was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://sportsperspectives.com/2017/11/15/coloplast-as-clpby-given-consensus-rating-of-sell-by-brokerages.html.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.